Is Fed disunity coming at just the wrong time? Bloomberg Opinion's Jonathan Levin talks about the Fed dissent and how it could affect inflation in the US. Opinion's Lisa Jarvis says the recent ruling on mifepristone is a threat not only to women's health, but also pharmaceutical innovation. Bloomberg Opinion editor Sarah Green Carmichael critiques complicated hiring practices, and columnist Lara Williams offers a warning: flights are about to get a lot more expensive. Amy Morris hosts.

<p>Is Fed disunity coming at just the wrong time? Bloomberg Opinion's Jonathan Levin talks about the Fed dissent and how it could affect inflation in the US. Opinion's Lisa Jarvis says the recent ruling on mifepristone is a threat not only to women's health, but also pharmaceutical innovation. Bloomberg Opinion editor Sarah Green Carmichael critiques complicated hiring practices, and columnist Lara Williams offers a warning: flights are about to get a lot more expensive. Amy Morris hosts.</p>

Get wide-ranging commentary on the latest in business, economics and politics on the Bloomberg Opinion podcast.

<p>Get wide-ranging commentary on the latest in business, economics and politics on the Bloomberg Opinion podcast.</p>

Wide-ranging commentary on the latest in business, economics and politics.

Bloomberg Opinion

Deeper conversations on the week's most significant developments. Tune in and join in!

Fed Disunity and the Mifepristone Court Battle

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/08e58abb-285d-46ba-ade0-afe901032d16/transcript

Advertisement